BLAKE BULGER: Open Payments
NPI 1861101586 · BARLING, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 22 payments from 9 companies in 2025. Trend: 2023 $345 · 2024 $138 · 2025 $395
Food & beverage: $367Education: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Corium, LLC | 4 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: VRAYLAR, REXULTI, COBENFY, SPRAVATO, ABILIFY MAINTENA, Azstarys, Jornay PM, CAPLYTA.
Industry payments across AR — which companies pay providers there.
